These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10150468)

  • 21. A single-institution retrospective study of causes of prolonged prothrombin time and activated partial thromboplastin time in the outpatient setting.
    Hazim AZ; Ruan GJ; Khodadadi RB; Slusser JP; Marshall AL; Pruthi RK
    Int J Lab Hematol; 2022 Feb; 44(1):209-215. PubMed ID: 34612006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The impact of heparin bolus from dysfunctional lumen of dual lumen central venous catheter on activated partial thromboplastin time during hemodialysis: is additional heparinization necessary?].
    Sefer S; Kes P; Raić B; Heinrich B; Degoricija V; Szavits-Nossan J
    Acta Med Croatica; 2006 Jun; 60(3):281-5. PubMed ID: 16933844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of drawing a discard tube on PT and APTT results in healthy adults.
    Bamberg R; Cottle JN; Williams JC
    Clin Lab Sci; 2003; 16(1):16-9. PubMed ID: 12587654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring unfractionated heparin with the aPTT: time for a fresh look.
    Eikelboom JW; Hirsh J
    Thromb Haemost; 2006 Nov; 96(5):547-52. PubMed ID: 17080209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies of phospholipid reagents used in coagulation II: factors influencing their sensitivity to heparin.
    Barrowcliffe TW; Gray E
    Thromb Haemost; 1981 Oct; 46(3):634-7. PubMed ID: 7314057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Difference in examination of coagulation function in heparin anticoagulant therapy between point of care tests and automatic coagulation analyzer].
    Li J; Cong YL; Tu GH; Yang L; Zhu BB; Jin L
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1269-71. PubMed ID: 17686264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mixing test for prolonged clotting time: clinical availability and problems].
    Uchiba M; Ando Y
    Rinsho Byori; 2009 Oct; 57(10):1004-12. PubMed ID: 19928499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a point-of-care coagulation analyzer on patients undergoing cardiopulmonary bypass surgery.
    Chavez JJ; Weatherall JS; Strevels SM; Liu F; Snider CC; Carroll RC
    J Clin Anesth; 2004 Feb; 16(1):7-10. PubMed ID: 14984853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of point-of-care activated partial thromboplastin time testing by comparison to laboratory-based assay for control of intravenous heparin.
    Douglas AD; Jefferis J; Sharma R; Parker R; Handa A; Chantler J
    Angiology; 2009; 60(3):358-61. PubMed ID: 19398428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reflex factor coagulation testing in patients with an unexplained prolonged aPTT: An institutional retrospective review.
    Mansory EM; Bahodi F; Phua CW
    Int J Lab Hematol; 2022 Feb; 44(1):202-208. PubMed ID: 34623751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of activated partial thromboplastin time to coronary events and bleeding in patients with acute coronary syndromes who receive heparin.
    Anand SS; Yusuf S; Pogue J; Ginsberg JS; Hirsh J;
    Circulation; 2003 Jun; 107(23):2884-8. PubMed ID: 12796128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Unsuspected prolonged activated partial thromboplastin time in emergency surgery. Diagnostic and therapeutic guide].
    Barrio J; Peris V; Asensio I; Molina I; López F; García V
    Rev Esp Anestesiol Reanim; 2002 Oct; 49(8):424-7. PubMed ID: 12455323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged aPTT after kidney transplantation due to transient lupus anticoagulants.
    Nybo M; Dieperink H; Kristensen SR
    Nephrol Dial Transplant; 2006 Apr; 21(4):1060-5. PubMed ID: 16384821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid removal of platelets from plasma utilizing the Hepcheck heparin removal filter.
    McGlasson DL; Ledford M; Barna L; Best HA; Hickman JR
    Blood Coagul Fibrinolysis; 1997 Jan; 8(1):16-20. PubMed ID: 9105633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activated partial thromboplastin time: new tricks for an old dogma.
    Lippi G; Favaloro EJ
    Semin Thromb Hemost; 2008 Oct; 34(7):604-11. PubMed ID: 19085761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
    Morabito S; Guzzo I; Solazzo A; Muzi L; Luciani R; Pierucci A
    J Nephrol; 2003; 16(4):566-71. PubMed ID: 14696760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of routine coagulation studies in emergency department patients with suspected acute coronary syndromes.
    Schwartz D
    Isr Med Assoc J; 2005 Aug; 7(8):502-6. PubMed ID: 16106775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring unfractionated heparin therapy: relationship between eight anti-Xa assays and a protamine titration assay.
    Kitchen S; Theaker J; Preston FE
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):137-44. PubMed ID: 10759006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The diagnostic accuracy of bedside and laboratory coagulation: procedures used to monitor the anticoagulation status of patients treated with heparin.
    Solomon HM; Mullins RE; Lyden P; Thompson P; Hudoff S
    Am J Clin Pathol; 1998 Apr; 109(4):371-8. PubMed ID: 9535388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.